Global In-Vitro Diagnostic Market Report ----------------------------------------------------- 2013
Executive Summary The process of performing a diagnostic test outside of a living organism in an artificial environment, usually a laboratory, is called invitro diagnostic (IVD). IVD is considered as an essential part of today s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Further, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run. A consistent increase has been observed in the global IVD industry over the past couple of years. Even in 2009, the IVD industry was unaffected by the economic and financial turmoil thereby proving the industry as recession proof. On the basis of technology, central lab immunoassay strongly dominated the IVD market followed by whole body glucose and clinical chemistry. Further, in case of IVD sale by test location, the market was led by testing at central labs, followed by point-of-care testing. The key factors driving growth of the global IVD industry include rising global healthcare expenditure, increasing aging population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases. Some of the noteworthy trends and developments of this industry include increasing demand for early diagnosis, expansion of point of care testing and growth of minimally invasive and non-invasive procedures. However, the growth of IVD industry is hindered by the strict regulatory compliance imposed on manufacturers. The report contains a comprehensive analysis of the global IVD industry along with the study of regional markets including Europe, Brazil and China. An intense competition is noted among few major players; Roche, Abbott, Siemens, J&J and Danaher. Apart from global competitive analysis, regional competitive landscape is also included in the report along with company profiles of the leading players in the market. By combining SPSS Inc. s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Anatomic Clinical Molecular POC/POL Hematology Flow Cytometry Microbiology Coagulation Blood Screen Immuno- Blood Screen Whole Blood Other Products % Growth US$ Billion The process of performing a diagnostic test outside of a living organism in an artificial environment, usually a laboratory, is called an in-vitro diagnostic. Global IVD Market (2007-2012) 2007 2008 2009 2010 2011 2012 The global IVD market was worth US$... billion at the end of 2012, up by notable %, compared to US$... billion in the prior year. The industry recorded an impressive CAGR of.% during the period spanning 2007 to 2012. Central lab accounted for the highest share of.% of the total sales of IVD tests in 2012, followed by OTC or self tests and point of care tests with respective shares of.% and.%. In terms of growth rate of IVD market segments, the five fastest growing segments are anatomic pathology, clinical molecular, point-of-care, immunoassay and hematology with respective growth rates of.%,.%,.%,.% and %. On the other hand, the slowest growing segments are blood screen molecular (.%), central lab clinical chemistry (.%), immune-hematology (.%), blood screen immunoassay (.%) and whole blood glucose (.%). Percentage Share of IVD Market by Test Location (2012) Growth of Segments of Global IVD Market (2011/2012) Central Labs OTC/Self Test Point Of Care
US$ Billion North America EMEA Asia Pacific Japan Latin America US$ Billion The modern IVD industry produces mainly three types of products namely; reagents, analytical instruments, and accessory products that are required to perform an array of diagnostic laboratory tests. Global IVD Market by Region (2012) North America was the market leader in the global IVD market with US$... billion sales in 2012, followed by EMEA (Europe, Middle East and Africa) with sales equivalent to US$... billion. As the US and European economic climate improves, an eventual rebound was observed in testing volumes and instrument purchases. Over the past few years, Europe is considered as one of the most of the most mature markets for the IVD industry. Witnessing a decline of.% in 2012, the European IVD market plummeted to US$... billion, compared to US$... billion in the prior year. Germany stands as the largest market for in-vitro diagnostics in Europe and accounted for a share of around.% share in the European IVD market in 2012. France is the second largest European IVD market, which represented around.% of the total revenues in 2012, followed by Italy and Spain, representing roughly % and.% share respectively in 2012. IVD Market in the Europe (2007-2012) IVD Market Share in Europe by Countries (2012) 2007 2008 2009 2010 2011 2012 EU-27 EU-27+EFTA Germany France Italy Spain UK Belgium Switzerland Netherlands Poland Others
US$ Billion US$ Billion The key factors driving growth of the global IVD industry include rising global healthcare expenditure, increasing aging population, accelerating global diabetic population and chronic and infectious diseases. China s In-Vitro Diagnostic Reagent Market Size (2007-2013E) 2008 2009 2010 2011 2012 2013E Marking an impressive increase of.%, the China s IVD reagent market was valued at US$... billion at the end of 2012, compared to US$... billion during the previous year. Moreover, through 2008 to 2012 the IVD market in China grew at a remarkable CAGR of.%. The increase can be attributed to the positive correlation of the aforementioned industry with the ever growing bio-product industry of China. The IVD market of Brazil reported revenues worth US$... billion in 2012 thereby representing an incline of.%, compared to US$... billion in 2010. The growth of the IVD market was reported at a CAGR of.% during the period spanning 2003 to 2012. As of 2012, Roche accounted for.% share in the China s IVD market. Danaher represented modest % share, immediately followed by Abbott and Siemens with market shares of.% each. Brazil IVD Market Revenues (2003-2012) Market Share of IVD Players in China (2012) 2003 2007 2010 2012 Roche Danaher Abbott Siemens Symex Mindray Hitachi biomeneux J&J DA AN Others
US$ Billion The IVD industry is operated by chiefly two groups: Medium Sized Companies and Large Pharmaceuticals Companies. Global IVD Market Share Breakdown by Company (2012) Global In Vitro Diagnostics Market (2007-2016F) Roche Abbott Siemens J&J Danaher biomerieux Others 2007 2008 2009 2010 2011 2012 2013F 2014F 2015F 2016F More than.% of the global IVD market is being reined by six major players thereby representing the consolidated structure of the market. Each of the six key players namely; Roche, Siemens, Abbott Diagnostics, Johnson and Johnson, biomerieux, and Danaher; has established technological platforms and offers diversified test menu to their customers. Roche, with % share, was the market leader as of 2012 followed by Abbott with.% market share. Siemens and J&J displayed a share of.% and.%, respectively, of the global IVD market. Furthermore, most of the top companies leading the global marketplace control the production distribution channels. The in-vitro diagnostic (IVD) industry is considered as one of the most lucrative segments of the global healthcare industry. The overall IVD industry is chiefly driven by increasing prevalence of chronic and infectious diseases, increasing patient awareness about importance of health, advancements in technology and novel product development. Furthermore, developed countries have a very strong foothold in the global IVD market. The demand for disease screening diagnostics is further expected to expand due to shift from reactive testing to proactive testing. The global IVD market is forecasted to grow by.% to reach US$... billion by the end of 2013, compared to US$... billion in 2012. The same is forecasted to reach US$... billion by the end of 2016 marking the growth of the IVD industry at a CAGR of.% during the period spanning 2007 to 2016. Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa